Virginia Retirement Systems’s BridgeBio Pharma BBIO Stock Holding History

Virginia Retirement Systems’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$715K	Sell	9,600 -8,450	-47%	-$592K	﹤0.01%	856
2026 Q1	$1.34M	Sell	18,050 -7,800	-30%	-$565K	0.01%	511
2025 Q4	$1.98M	Buy	25,850 +15,350	+146%	+$1.01M	0.01%	421
2025 Q3	$545K	Buy	10,500 +5,200	+98%	+$254K	﹤0.01%	736
2025 Q2	$229K	Sell	5,300 -4,000	-43%	-$145K	﹤0.01%	881
2025 Q1	$322K	Buy	+9,300	New	+$314K	﹤0.01%	868

Other funds holding BBIO

Jupiter Topco New York $245B AUM

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Virginia Retirement Systems's BBIO Position: Q2 2026 in Review

Virginia Retirement Systems reduced its BridgeBio Pharma (BBIO) stake by 47% in Q2 2026, selling an estimated $592K and leaving 9,600 shares worth $715K. The position accounts for ﹤0.01% of the portfolio, ranked #856.

Virginia Retirement Systems first reported a position in BBIO in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.98M in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

Virginia Retirement Systems held 9,600 shares of BridgeBio Pharma worth $715K as of Q2 2026.
Virginia Retirement Systems sold 8,450 BridgeBio Pharma shares in Q2 2026, an estimated $592K.
BridgeBio Pharma made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #856 holding.
Virginia Retirement Systems first reported a position in BridgeBio Pharma in Q1 2025 and has held it in 6 quarters since.
Virginia Retirement Systems's BridgeBio Pharma position peaked at $1.98M in Q4 2025.
474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.